In this episode, Matt Oguz meets with visionary entrepreneur Alex Fielding to discuss the groundbreaking mission of Privateer Space, a company Alex co-founded with Apple co-founder Steve Wozniak. Privateer is dedicated to building the infrastructure for sustainable space exploration, focusing on geospatial AI and real-time Earth observation. Alex shares insights into the challenges and opportunities in the space domain, emphasizing the importance of keeping space safe and accessible for future generations. Tune in to explore how Privateer is reshaping the future of space and the exciting innovations on the horizon.

This podcast does not offer financial, legal, or tax advice, nor does it recommend any specific investments. Investment involves risk your investment. AI tools may be used in creation or edits of this podcast. The information presented here may not be complete or accurate, and no warranties are provided. Past results do not guarantee future performance in any case. It is essential that listeners conduct their own thorough research and consult with a qualified financial, legal, or tax professional before making any investment decisions.

Teknoloji dünyasının duayenlerinden Ersin Pamuksüzer ile değişen ve yüksek rekabetçi dünyada başarılı olmak için gayret gösterirken hem kendimize hem de yakın çevremize faydalı, yardımcı, ve etkili olmanın püf noktalarını konuştuğumuz özel podcast.

This podcast does not offer financial, legal, or tax advice, nor does it recommend any specific investments. Investment involves risk your investment. AI tools may be used in creation or edits of this podcast. The information presented here may not be complete or accurate, and no warranties are provided. Past results do not guarantee future performance in any case. It is essential that listeners conduct their own thorough research and consult with a qualified financial, legal, or tax professional before making any investment decisions.

In this episode of Strata, Matt Oguz sat down with Robert Carlisle, cofounder and CEO of Argo Space—a next-generation space company tackling one of the hardest problems in aerospace: building infrastructure for orbit.

Robert shares his journey from working at SpaceX—alongside his two brothers, now also cofounders—to launching Argo with a mission to deliver modular, scalable solutions for propulsion, payload integration, and in-space operations.

We talk about what it takes to start a space company in a capital-intensive, risk-sensitive industry, the transition from elite aerospace to startup life, and why Argo believes the next big frontier isn't launch—it’s what happens after you're in orbit.

For investors and founders interested in space, defense, and frontier tech, this is a conversation full of hard-earned insight and forward-looking vision.

This podcast does not offer financial, legal, or tax advice, nor does it recommend any specific investments. Investment involves risk your investment. AI tools may be used in creation or edits of this podcast. The information presented here may not be complete or accurate, and no warranties are provided. Past results do not guarantee future performance in any case. It is essential that listeners conduct their own thorough research and consult with a qualified financial, legal, or tax professional before making any investment decisions.

In this episode of Deep Dive, we break down the headline-grabbing pledge between President Donald Trump and Crown Prince Mohammed bin Salman, which touts up to $1 trillion in commercial deals across defense, tech, energy, and more.

We explore what this means for U.S. investors, the sectors that may actually benefit, and how capital commitments on this scale shape geopolitical alignment—and risk.

This podcast does not offer financial, legal, or tax advice, nor does it recommend any specific investments. Investment involves risk your investment. AI tools may be used in creation or edits of this podcast. The information presented here may not be complete or accurate, and no warranties are provided. Past results do not guarantee future performance in any case. It is essential that listeners conduct their own thorough research and consult with a qualified financial, legal, or tax professional before making any investment decisions.

Quantum computing is no longer five years away. In this episode of Signals from Strata, Matt Oguz, CIO at Venture Science, breaks down how quantum is already driving real-world breakthroughs—from drug discovery and materials design to battery innovation and logistics optimization.

You'll hear why quantum computing doesn’t replace AI, but complements it—and why Venture Science is actively backing quantum companies today, including early investments like PsiQuantum. Matt explores the emerging hybrid stack of AI + quantum, and why this convergence could define the next decade of innovation.

Whether you're an investor, founder, or just curious about what's next, this five-minute briefing delivers clarity on a complex topic—and why Strata is leaning in.

This podcast does not offer financial, legal, or tax advice, nor does it recommend any specific investments. Investment involves risk your investment. AI tools may be used in creation or edits of this podcast. The information presented here may not be complete or accurate, and no warranties are provided. Past results do not guarantee future performance in any case. It is essential that listeners conduct their own thorough research and consult with a qualified financial, legal, or tax professional before making any investment decisions.

In this episode of Venture Recap, Matt Oguz sat down with Dermot Tierney, co-founder and COO of AMPLY Discovery, a groundbreaking company reimagining drug discovery at the intersection of AI, synthetic biology, and evolutionary science.

Dermot shares how AMPLY’s platform, AMPLYfolioAI, leverages nature’s own R&D engine—evolution—to find novel molecules that can fight cancer, drug-resistant infections, and more. We explore the company's unique "drug discovery studio" model, how it's flipping traditional biotech economics, and why the next generation of therapeutics might come from the genomic dark matter of frogs, fungi, and everything in between.

We also dive into Dermot's experience transitioning from university tech transfer to full-time founder, and how his commercialization mindset is helping AMPLY scale faster, smarter, and more impactfully.

Whether you're interested in deep tech, biotech, or what’s next in AI-powered healthcare, this episode is packed with insight, optimism, and practical takeaways.

This podcast does not offer financial, legal, or tax advice, nor does it recommend any specific investments. Investment involves risk your investment. AI tools may be used in creation or edits of this podcast. The information presented here may not be complete or accurate, and no warranties are provided. Past results do not guarantee future performance in any case. It is essential that listeners conduct their own thorough research and consult with a qualified financial, legal, or tax professional before making any investment decisions.

In this episode, Matt Oguz sat down with Paul Newman CBE—renowned roboticist, BP Professor of Information Engineering at the University of Oxford, founder of the Oxford Mobile Robotics Group, and CEO of autonomous vehicle company OXA.

Paul takes us inside the world of robotics and autonomy, sharing stories from his early days at Oxford to building one of the most forward-thinking companies in self-driving technology.

We talk about what it means to turn cutting-edge science into real-world systems, the leap from academia to entrepreneurship, and how Paul sees the world—not just through sensors and data, but through the eyes of a scientist, a builder, and, as you'll quickly hear, a very entertaining human being.

Whether you’re a technologist, investor, or just curious about the future of autonomy, this episode is full of insight, wit, and big ideas.

This podcast does not offer financial, legal, or tax advice, nor does it recommend any specific investments. Investment involves risk your investment. AI tools may be used in creation or edits of this podcast. The information presented here may not be complete or accurate, and no warranties are provided. Past results do not guarantee future performance in any case. It is essential that listeners conduct their own thorough research and consult with a qualified financial, legal, or tax professional before making any investment decisions.

In this episode we dive into the fascinating world of gut health and the microbiome—an area of science that’s rapidly reshaping how we understand the connection between the body and the brain.

Venture Science founding partner Matt Oguz sits down with the Founder and CEO of Jona, a pioneering company at the forefront of microbiome diagnostics and personalized gut health insights.

Together, they explore:

• The link between gut health and chronic conditions like obesity, inflammation, and anxiety
• How Jona is using cutting-edge science to turn microbiome data into actionable health guidance
• Why the gut is emerging as one of the most important systems in preventative medicine
• The founder’s journey from scientific leadership roles at HeartFlow and Paige AI to launching Jona

Whether you're an investor curious about the next frontier in healthcare or simply fascinated by the science of well-being, this episode offers powerful insights into a field that's only just beginning to show its potential.

This podcast does not offer financial, legal, or tax advice, nor does it recommend any specific investments. Investment involves risk your investment. AI tools may be used in creation or edits of this podcast. The information presented here may not be complete or accurate, and no warranties are provided. Past results do not guarantee future performance in any case. It is essential that listeners conduct their own thorough research and consult with a qualified financial, legal, or tax professional before making any investment decisions.

The traditional 10-year VC model is outdated in a world where private and public markets are converging and technology-driven opportunities are accelerating. In this episode, Matt Oguz, founding partner at Venture Science, breaks down why venture capital needs a hybrid, evergreen approach that offers flexibility, liquidity, and long-term upside. We discuss how AI and quantum computing are driving the next trillion-dollar opportunities and why investors and entrepreneurs must rethink their strategies to stay ahead.

This podcast does not offer financial, legal, or tax advice, nor does it recommend any specific investments. Investment involves risk your investment. AI tools may be used in creation or edits of this podcast. The information presented here may not be complete or accurate, and no warranties are provided. Past results do not guarantee future performance in any case. It is essential that listeners conduct their own thorough research and consult with a qualified financial, legal, or tax professional before making any investment decisions.

Venture capital has long been the go-to strategy for investing in technology, but is it still enough? In this episode, we explore why a complete tech investment strategy must go beyond early-stage startups to include publicly traded technology giants like Google, Apple, Microsoft, and Nvidia. We discuss how AI, Quantum Computing, and deep tech are evolving, why public markets still offer massive upside, and how investors can build a hybrid portfolio that captures the full lifecycle of innovation. If you're serious about tech investing, this is an episode you won’t want to miss.

This podcast does not offer financial, legal, or tax advice, nor does it recommend any specific investments. Investment involves risk your investment. AI tools may be used in creation or edits of this podcast. The information presented here may not be complete or accurate, and no warranties are provided. Past results do not guarantee future performance in any case. It is essential that listeners conduct their own thorough research and consult with a qualified financial, legal, or tax professional before making any investment decisions.